Login

Categories

Consumer Corporate Energy Entertainment Experts Financials Healthcare Industrial Law Markets Media Mining Private Equity Real Estates Sports Startups Technology Venture Capital

Recent Videos

00:10:00
Instem PLC's CEO Phil Reason discusses the company's robust 2022 financial performance, marked by a 28% revenue growth, 32% increase in underlying earnings, and anticipated benefits from industry consolidation in 2023, alongside recent successes such as h
00:10:00
Planet MicroCap interviews Intellicheck, Inc.'s CEO Bryan Lewis via Zoom to discuss the company's current status and future prospects.|Bryan Lewis President & CEO of Intellicheck Inc
00:00:00
Kancera – 5 mar 2024 - Peter Selin, CEO, Kancera
00:00:00
Kancera -27 november 2023 - Peter Selin, CEO, Kancera
00:00:00
Mike Lampron – CEO - Mach7 Technologies
00:00:00
Jaguar Health CEO Lisa Conte
00:00:00
Japara Healthcare (ASX:JHC):Andrew Sudholz , CEO -Andrew Sudholz , CEO, Japara Healthcare Ltd
00:00:00
Japara Healthcare (JHC): Andrew Sudholz, Chief Executive Officer & Executive Director
00:00:00
Kancera at Carlsquare Nordic Life Science Investor Day 6 Dec. 2023 - Peter Selin, CEO, Kancera
00:00:00
Kromek Group rounds off "landmark year" - Arnab Basu, Chief Executive Officer, Kromek Group
00:00:00
Kromek Group boss Arnab Basu tells investors to expect 'robust news flow' - Arnab Basu, Chief Executive Officer, Kromek Group
00:00:00
Kromek Group: Interview with CEO Arnab Basu on group prospects - Arnab Basu, Chief Executive Officer, Kromek Group
00:00:00
Rick Carreon, Managing Director & Chief Executive Officer, ImpediMed Ltd
00:00:00
Emergence 2024: Presentation by Leslie Chong, Managing Director and CEO, Imugene Ltd - Leslie Chong | CEO & Managing Director, Imugene Ltd
00:00:00
Imugene progresses onCARlytics solid tumour trial to combination arm - Leslie Chong | CEO & Managing Director, Imugene Ltd
00:00:00
Imugene Ltd MD and CEO shares with JustStocks plans for Phase 1 onCARlytics Combination Study - Leslie Chong | CEO & Managing Director, Imugene Ltd
00:00:00
Imugene doses first patient in intravenous monotherapy arm of Phase 1 clinical trial - Leslie Chong | CEO & Managing Director, Imugene Ltd
00:00:00
Imugene sees positive early signals in Phase 1 VAXINIA study - Leslie Chong | CEO & Managing Director, Imugene Ltd
00:00:00
Imugene Commences new PD1-Vaxx Bowel Cancer Trial - Leslie Chong | CEO & Managing Director, Imugene Ltd
00:00:00
CEO presentation AGM2021 - Andreas Andersson, CEO, Intervacc

© 2017 - Neuhu+